Cardiovascular disease - the leading global cause of death Nonetheless, use of semaglutide could help address CVD, which remains the leading cause of mortality around the world, and obesity, which is still an epidemic, Cynthia Jackevicius of Western University of Health Sciences emphasised the potential population impact of semaglutide, stating that it could have a profound effect on reducing morbidity and mortality from cardiovascular disease

Here's the clinical summary: Mechanism: GLP-1 receptor agonists can cause nausea-related reduced oral intake and altered skin hydration dehydrated skin is more susceptible to UV damage and less able to repair UV-induced DNA strand breaks Weight loss & UV sensitivity: Significant weight loss (common with GLP-1 medications) can expose areas of skin previously shaded by body fat new UV exposure patterns emerge as body composition changes Drug interaction risk: Many GLP-1 patients are also on metformin, statins, or ACE inhibitors all of which carry independent photosensitivity risks that compound with GLP-1 effects Outdoor exercise motivation: GLP-1 medications often increase motivation for outdoor exercise as energy levels improve patients starting new outdoor routines should simultaneously begin UV protection habits Practical protection priority: For patients using GLP-1 medications for weight management who are increasing outdoor activity, a UPF 50+ umbrella provides consistent, sweat-free UV protection during walks, outdoor exercise, and recreational activities Ozempic & Sun Sensitivity: Expert FAQ Does Ozempic (semaglutide) cause photosensitivity as a direct side effect

Carbohydrates and fats fill in what space remains after protein is accounted for
[31] Bene J, Hadzsiev K, Melegh B
pubmed.ncbi.nlm.nih.gov/9849822 Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
While some of these effects may be cosmetic in nature, such as Ozempic face, other reports purport a more present danger to patients, including reports of blindness